Furthermore, metabolic implications of the JAK-STAT signaling cascade are evident; JAK3 deficiency correlates with insulin resistance, while variations in Tyk2 and Stat6 levels are associated with metabolic disorders such as obesity and glucose intolerance [37, 139–142]. Here, SOAT1 is linked to obesity disorder.